E-Cig Refills by InLife | Manufactured In An FDA Registered Lab
Following a meeting in the UK on Friday of the MHRA it seems that further consultation will be taken before any action or decision is announced. It seems from reports that the members of the MHRA were badly informed about the industry and that thanks to a good representation by vendors of major e-cig suppliers that much was bought to their attention that had not been considered before.
inLife are still the only company that manufactures their e-cig refills in an FDA registered lab (to our knowledge) and is at the forefront of ensuring the safety of the product supplied to its customers.
Report of MHRA Meeting ( taken from ecigarettedirect.co.uk)
MHRA Meeting
At 2.20 the MHRA meeting took place. According to Jean, the MHRA were very uninformed about the product (admitting this themselves). The MHRA showed images of numerous other smoking alternatives, and were taken aback to find that not one of the the 35 retailers supplied them. They were also surprised that not one of us claimed the e-cigarette was a smoking cessation aid.
The Vendors emphasised that the electronic cigarette was not a smoking cessation aid, and that it should be regulated by Trading Standards, and not by the MHRA, as it is at present designated as a General Sales Product by HMRC. Katherine Devlin explained that she had prepared an alternative regulatory framework, in consultation with various leading companies. She proposed that the industry should be voluntary regulated, with a Code of Practice to be agreed with Trading Standards and their governing body, Failure to comply would be alerted to trading standards as required by the industry as well as by TS normal checks.
We emphasised that the device is already regulated, by Trading Standards officers, and that calling it “unregulated” – as the MHRA has being doing – is simply not true.
Licensing
Metabolism
The physician present confirmed that blood absorption levels would have to be tested. There is a level above which nicotine affects a person’s metabolism. When it is above this level, it needs to need to be regulated in the UK. Our products may well be below this level, but unfortunately the attending physician did not know what level this is. It was suggested by those attending that we might have to increases the level of delivered nicotine to become legally described as a harm reduction aid.
Licensing fees
Concern was expressed over the level of funding vendors would have to pay for licensing, which is estimated to be hundreds of thousands of pounds per electronic cigarette. It was recognised that this is totally unfeasible for a young entrepreneurial industry with a new and innovative device attractive to existing smokers.
In response to questions about time scale, it appears the e-cigarette industry has at the very least until September. All three options remain in place, including stopping sale of the e-cigarettes within 21 days of a decision being taken.
MHRA Responses
The MHRA has had over 1000 responses. Further responses are being accepted by the MHRA until June 9th.
